| Literature DB >> 21914166 |
Seetha Jaganathan1, Ooi P Toung, Phang L Yee, Tan D Yew, Choo P Yoon, Lim B Keong.
Abstract
BACKGROUND: Porcine circovirus type 2 is the primary etiological agent associated with a group of complex multi-factorial diseases classified as Porcine Circovirus Associated Diseases (PCVAD). Sporadic cases reported in Malaysia in 2007 caused major economic losses to the 2.2 billion Malaysian ringgit (MYR) (approximately 0.7 billion US dollar) swine industry. The objective of the present study was to determine the association between the presence of PCV2 and occurrences of PCVAD.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21914166 PMCID: PMC3184107 DOI: 10.1186/1743-422X-8-437
Source DB: PubMed Journal: Virol J ISSN: 1743-422X Impact factor: 4.099
Figure 1Nucleotide sequence alignment of a fragment of the complete genome of PCV1 and PCV2 found in this study. Alignments were performed using ClustalW. The unique NcoI restriction enzyme site that is present in all PCV2 [10] isolates is underlined.
PCV2 isolates used in this study and other isolates reported previously
| Genotype | Name | Geographic Location | Reference or source |
|---|---|---|---|
| PCV2b | Mal 001- | Malaysia | This study |
| Mal 002- | Malaysia | This study | |
| Mal 003- | Malaysia | This study | |
| Mal 004- | Malaysia | This study | |
| Mal 005- | Malaysia | This study | |
| Mal 006- | Malaysia | This study | |
| Mal 007- | Malaysia | This study | |
| Mal 008- | Malaysia | This study | |
| Mal 009- | Malaysia | This study | |
| Mal 010- | Malaysia | This study | |
| Mal 011- | Malaysia | This study | |
| Mal 012- | Malaysia | This study | |
| Mal 013- | Malaysia | This study | |
| PCV1 | Ireland | Genbank | |
| PCV1/2a | Canada | Genbank | |
| Canada | Genbank | ||
| Canada | Genbank | ||
| PCV2a | USA | Genbank | |
| USA | Genbank | ||
| Korea | Genbank | ||
| Canada | Genbank | ||
| Japan | Genbank | ||
| Korea | Genbank | ||
| USA | Genbank | ||
| China | Genbank | ||
| Taiwan | Genbank | ||
| PCV2b | Netherlands | Genbank | |
| Portugal | Genbank | ||
| Korea | Genbank | ||
| Portugal | Genbank | ||
| China | Genbank | ||
| China | Genbank | ||
| Korea | Genbank | ||
| China | Genbank | ||
| China | Genbank | ||
| PCV2c | Denmark | Genbank | |
| Denmark | Genbank | ||
| Denmark | Genbank | ||
| PCV2d | China | Genbank | |
| China | Genbank | ||
| China | Genbank | ||
| China | Genbank | ||
| China | Genbank | ||
| China | Genbank | ||
| Germany | Genbank | ||
| China | Genbank | ||
| China | Genbank | ||
Sequence identity matrix of the capsid protein (ORF2) and the nucleotide alignment of the whole genome of the PCV2 isolates found in Malaysia
| Sequences | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (1) | 98.4 | 98.6 | 98.4 | 98.6 | 99.2 | 99.3 | 98.4 | 99.1 | 99 | 98.3 | 98.4 | 98.6 | 98.3 | 99.5 | 99.5 | 99.2 | 99.2 | 99.6 | 99.7 | 99.5 | 76.2 | |
| (2) | 98.7 | 99.6 | 99.7 | 99.5 | 97.7 | 98 | 97.5 | 98.9 | 98.9 | 99.5 | 99.7 | 99.6 | 99.4 | 98 | 98.1 | 98 | 97.9 | 98.3 | 98.2 | 98.1 | 76.5 | |
| (3) | 98.7 | 98.7 | 99.6 | 99.9 | 97.9 | 98.3 | 97.9 | 99.3 | 99.3 | 99.6 | 99.7 | 99.7 | 99.4 | 98.4 | 98.5 | 98.3 | 98.3 | 98.6 | 98.4 | 98.5 | 76.4 | |
| (4) | 96.5 | 96.1 | 96.5 | 99.7 | 97.7 | 98 | 97.6 | 99.1 | 99 | 99.6 | 99.7 | 99.6 | 99.5 | 98.1 | 98.3 | 98 | 98 | 98.4 | 98.2 | 98.3 | 76.3 | |
| (5) | 97.4 | 96.9 | 96.9 | 94.8 | 97.9 | 98.3 | 97.9 | 99.4 | 99.2 | 99.5 | 99.6 | 99.7 | 99.4 | 98.4 | 98.5 | 98.3 | 98.3 | 98.6 | 98.4 | 98.5 | 76.3 | |
| (6) | 96.5 | 96.1 | 96.1 | 94 | 99.1 | 98.8 | 97.9 | 98.4 | 98.4 | 97.6 | 97.7 | 98 | 97.6 | 98.7 | 98.7 | 98.4 | 98.4 | 98.8 | 98.9 | 98.7 | 75.5 | |
| (7) | 96.1 | 95.7 | 95.7 | 93.5 | 98.7 | 99.5 | 98.1 | 98.8 | 98.7 | 98 | 98 | 98.3 | 97.9 | 98.9 | 98.9 | 98.5 | 98.6 | 99 | 99 | 98.8 | 76 | |
| (8) | 96.5 | 96.1 | 96.1 | 94 | 98.7 | 99.5 | 99.1 | 98.4 | 98.3 | 97.5 | 97.6 | 97.8 | 97.5 | 98.3 | 98.4 | 97.7 | 98.1 | 98.5 | 98.3 | 98.2 | 75.4 | |
| (9) | 95.7 | 95.2 | 95.2 | 93.1 | 97.8 | 98.7 | 99.1 | 99.1 | 99.8 | 98.9 | 99 | 99.2 | 98.9 | 98.9 | 99 | 98.5 | 98.8 | 99.1 | 98.9 | 99 | 76.4 | |
| (10) | 97.4 | 96.9 | 96.9 | 94.8 | 99.5 | 98.7 | 98.2 | 99.1 | 98.2 | 99.1 | 99.1 | 99.3 | 99 | 98.8 | 98.9 | 98.5 | 98.7 | 99 | 98.9 | 98.9 | 76.5 | |
| (11) | 96.1 | 95.7 | 95.7 | 93.5 | 98.2 | 99.1 | 99.5 | 99.5 | 99.5 | 98.7 | 99.5 | 99.5 | 99.6 | 98 | 98.1 | 98 | 97.9 | 98.3 | 98.1 | 98.1 | 76.4 | |
| (12) | 96.1 | 95.7 | 95.7 | 93.5 | 98.2 | 99.1 | 99.5 | 99.5 | 99.5 | 98.7 | 100 | 99.7 | 99.6 | 98.1 | 98.3 | 98 | 98 | 98.4 | 98.2 | 98.3 | 76.4 | |
| (13) | 96.5 | 96.1 | 96.1 | 94 | 98.7 | 99.5 | 99.1 | 100 | 99.1 | 99.1 | 99.5 | 99.5 | 99.6 | 98.3 | 98.4 | 98.3 | 98.2 | 98.5 | 98.5 | 98.4 | 76.4 | |
| (14) | 96.1 | 95.7 | 95.7 | 93.5 | 98.2 | 99.1 | 99.5 | 99.5 | 99.5 | 98.7 | 100 | 100 | 99.5 | 98 | 98.1 | 97.9 | 97.9 | 98.3 | 98.1 | 98.1 | 76.3 | |
| (15) | 100 | 98.7 | 98.7 | 96.5 | 97.4 | 96.5 | 96.1 | 96.5 | 95.7 | 97.4 | 96.1 | 96.1 | 96.5 | 96.1 | 99.5 | 98.8 | 99.2 | 99.6 | 99.3 | 99.3 | 76 | |
| (16) | 100 | 98.7 | 98.7 | 96.5 | 97.4 | 96.5 | 96.1 | 96.5 | 95.7 | 97.4 | 96.1 | 96.1 | 96.5 | 96.1 | 100 | 98.8 | 99.3 | 99.7 | 99.3 | 99.3 | 76.1 | |
| (17) | 98.7 | 97.4 | 97.4 | 95.2 | 96.9 | 97 | 96.5 | 97 | 96.1 | 96.9 | 96.5 | 96.5 | 97 | 96.5 | 98.7 | 98.7 | 98.5 | 98.9 | 99 | 99 | 76.1 | |
| (18) | 99.1 | 97.8 | 97.8 | 95.7 | 96.9 | 96.1 | 95.7 | 96.1 | 95.2 | 96.9 | 95.7 | 95.7 | 96.1 | 95.7 | 99.1 | 99.1 | 97.8 | 99.4 | 99.2 | 99 | 75.9 | |
| (19) | 99.5 | 98.2 | 98.2 | 96.1 | 96.9 | 96.1 | 95.7 | 96.1 | 95.2 | 96.9 | 95.7 | 95.7 | 96.1 | 95.7 | 99.5 | 99.5 | 98.2 | 98.7 | 99.4 | 99.4 | 76.1 | |
| (20) | 100 | 98.7 | 98.7 | 96.5 | 97.4 | 96.5 | 96.1 | 96.5 | 95.7 | 97.4 | 96.1 | 96.1 | 96.4 | 96.1 | 100 | 100 | 98.7 | 99.1 | 99.5 | 99.3 | 76.2 | |
| (21) | 99.5 | 98.5 | 98.2 | 96.1 | 97.8 | 97 | 96.5 | 97 | 96.1 | 97.8 | 96.5 | 96.5 | 97.1 | 96.5 | 99.5 | 99.5 | 99.1 | 98.7 | 99.1 | 99.5 | 76.4 | |
| (22) | 67.6 | 66.9 | 67.7 | 66.9 | 67.3 | 66.8 | 66.8 | 65.1 | 68 | 68.5 | 67.3 | 67.3 | 67.7 | 67.3 | 67.6 | 67.6 | 67.2 | 67.2 | 67.2 | 67.6 | 67.6 | |
PCV2 isolates found in Malaysia were compared with other PCV2b isolates and PCV1. Sequence identity scores for the other PCVs are not shown. The upper right portion is the sequence identity scores of the nucleotide alignment of the whole genome of PCV's; the lower portion is the amino acid sequence identity scores for the capsid protein (ORF2) of PCV2b. The highest nucleotide similarity scores for the Malaysian isolates are shown in bold.
Figure 2Amino acid sequence alignment of the putative capsid protein (ORF2) of the PCV2b cluster from this study. Deletions are indicated by hyphens. Identical sequences are doted. The arrow points at position 88-89. The circled portion denotes the mutations at the stop codon of the putative capsid protein resulting in a lysine (K) residue elongation at the C terminus of the ORF2 [26,28].
Figure 3Phylogenetic analysis of the whole genome of the PCV2 isolates from this study with other sequences from Genbank. The sequences used to build this tree are cited in Table 1. The phylogenetic tree was constructed using the Neighbour-Joining Method and the image was reduced to 50%. Isolates derived from this study are indicated by the rotated black square. The evolutionary distances were computed using the Maximum Composite Likelihood method. Analyses were conducted using Mega 5.
Primer pairs used for screening the suspected cases and for sequencing the complete genome of PCV2
| Primer | Sequence (5'-3') | Size of PCR Product (bp) | Nucleotide position | PCR step | Reference |
|---|---|---|---|---|---|
| PCV-1 forward | CTC GGC AGC GTC AGT GAA AA | 570 | 800-819 | First step (xPCR) | [ |
| PCV-1 reverse | AAA TTA CGG GCC CAC TGG CT | 1350-1369 | |||
| PCV-2 forward | CGG ATA TTG TAG TCC TGG TCG | 481 | 1095-1115 | ||
| PCV-2 reverse | ACT GTC AAG GCT ACC ACA GTC A | 1549-1570 | |||
| PCV-1 forward | CCT TCC GAG GAG GAG AAA AAC | 491 | 879-900 | Nested PCR (nPCR) | |
| PCV-1 reverse | AAA TTA CGG GCC CAC TGG CT | 1350-1369 | |||
| PCV-2 forward | GGT TTG GGT GTG AAG TAA CGG G | 329 | 1242-1263 | ||
| PCV-2 reverse | ACT GTC AAG GCT ACC ACA GTC A | 1549-1570 | |||
| CV1-forward | AGG GCT GTG GCC TTT GTT AC | 989 | 1336-1355 | Sequencing | [ |
| CV2-reverse | TCT TCC AAT CAC GCT TCT GC | 536-556 | |||
| CV3-forward | TGG TGA CCG TTG CAG AGC AG | 1093 | 453-471 | ||
| CV4-reverse | TGG GCG GTG GAC ATG ATG AG | 1525-1544 | |||
Figure 4Gel electrophoresis image of the multiplex PCR used for the screening of PCV1 and PCV2. The amplicon size for PCV1 is 491 bp and the amplicon size for PCV2 is 329 bp [39].
Figure 5Gel electrophoresis images of the 2 overlapping fragments that amplify the whole PCV2 genome [10,23]. The amplicon sizes for the two overlapping fragments are 989 bp (Lane 1) and 1092 bp (Lane 2).